JP7457713B2 - 軟骨再生促進用組成物 - Google Patents

軟骨再生促進用組成物 Download PDF

Info

Publication number
JP7457713B2
JP7457713B2 JP2021537688A JP2021537688A JP7457713B2 JP 7457713 B2 JP7457713 B2 JP 7457713B2 JP 2021537688 A JP2021537688 A JP 2021537688A JP 2021537688 A JP2021537688 A JP 2021537688A JP 7457713 B2 JP7457713 B2 JP 7457713B2
Authority
JP
Japan
Prior art keywords
composition
promoting
cartilage regeneration
cartilage
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021537688A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021024801A1 (https=
Inventor
祐多 大塚
亜由太 船木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of JPWO2021024801A1 publication Critical patent/JPWO2021024801A1/ja
Application granted granted Critical
Publication of JP7457713B2 publication Critical patent/JP7457713B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2021537688A 2019-08-02 2020-07-21 軟骨再生促進用組成物 Active JP7457713B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019143144 2019-08-02
JP2019143144 2019-08-02
PCT/JP2020/028306 WO2021024801A1 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Publications (2)

Publication Number Publication Date
JPWO2021024801A1 JPWO2021024801A1 (https=) 2021-02-11
JP7457713B2 true JP7457713B2 (ja) 2024-03-28

Family

ID=74503458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537688A Active JP7457713B2 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Country Status (9)

Country Link
EP (1) EP4008401A4 (https=)
JP (1) JP7457713B2 (https=)
KR (1) KR20220042403A (https=)
CN (1) CN114206330A (https=)
AU (1) AU2020324628A1 (https=)
CA (1) CA3147400A1 (https=)
PH (1) PH12022550260A1 (https=)
TW (1) TW202120078A (https=)
WO (1) WO2021024801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457353B2 (ja) * 2020-04-28 2024-03-28 学校法人北陸大学 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
US20240390407A1 (en) * 2021-09-17 2024-11-28 Hokuriku University Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter
WO2025031857A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising carboxamides
CN117736980B (zh) * 2024-02-20 2024-05-10 广东先康达生物科技有限公司 脂肪间充质干细胞转化成软骨细胞的诱导分化培养基及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002284A (ja) 2001-11-30 2004-01-08 Ezaki Glico Co Ltd リウマチの症状改善用飲食品および医薬
JP2007508371A (ja) 2003-10-15 2007-04-05 ケイエムエスアイ コーポレーション リミテッド 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
JP2016520603A (ja) 2013-05-29 2016-07-14 ネステク ソシエテ アノニム 軟骨破壊における使用のための組成物
JP2016539090A (ja) 2013-10-14 2016-12-15 ネステク ソシエテ アノニム 滑膜炎の治療及び予防のための抗炎症植物性栄養素

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis
RU2521227C1 (ru) * 2013-03-28 2014-06-27 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита, остеопороза и остеоартроза суставов
JP6742575B2 (ja) 2015-07-02 2020-08-19 株式会社東洋新薬 関節機能改善組成物
KR101794503B1 (ko) * 2016-03-24 2017-11-08 주식회사 티제이씨라이프 강글리오사이드 ｇｍ３를 함유하는 연골세포 분화 유도용 조성물 및 이의 이용
CN108938618B (zh) * 2018-06-25 2022-04-22 中国科学院动物研究所 延缓人间充质干细胞衰老的化合物及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002284A (ja) 2001-11-30 2004-01-08 Ezaki Glico Co Ltd リウマチの症状改善用飲食品および医薬
JP2007508371A (ja) 2003-10-15 2007-04-05 ケイエムエスアイ コーポレーション リミテッド 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
JP2016520603A (ja) 2013-05-29 2016-07-14 ネステク ソシエテ アノニム 軟骨破壊における使用のための組成物
JP2016539090A (ja) 2013-10-14 2016-12-15 ネステク ソシエテ アノニム 滑膜炎の治療及び予防のための抗炎症植物性栄養素

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BMC Complementary and Alternative Medicine，2017年，17:242
Drug Dev Res.，2019年，80(3), 360-367
J Cell Biochem.，2019年，120(9) :14628-14635.，https://doi.org/10.1002/jcb.28724，First published: 22 April 2019
J Cell Mol Med.，2019年，23(6), 4395-4407
Journal of Inflammation (Web)，2018年，15 : 14
Mol. Nutr. Food Res.，2018年，62, e1800202

Also Published As

Publication number Publication date
PH12022550260A1 (en) 2022-11-21
CN114206330A (zh) 2022-03-18
CA3147400A1 (en) 2021-02-11
WO2021024801A1 (ja) 2021-02-11
AU2020324628A1 (en) 2022-03-10
EP4008401A1 (en) 2022-06-08
KR20220042403A (ko) 2022-04-05
JPWO2021024801A1 (https=) 2021-02-11
TW202120078A (zh) 2021-06-01
EP4008401A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
JP7457713B2 (ja) 軟骨再生促進用組成物
DK2628484T3 (en) Trombocytrige plasma compositions
JP2012176949A (ja) ビタミンｄ化合物の使用
KR100946822B1 (ko) 칼슘 함유 조직 강화제 및 그 용도
EP4376819A1 (en) Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals
CN115867289B (zh) 含有nr及/或nmn与芝麻素类的组合物
JP6930037B2 (ja) 脳卒中の予防又は治療用組成物
JP6716330B2 (ja) ウロプラキン発現促進剤
JP2018501294A (ja) タウリンのコロナウイルス属及び／又はロタウイルス属のウィルスにより引き起こされる疾患の予防及び／又は治療における応用
EP1776956A1 (en) Preventive and/or therapeutic agent for calcipenia
HK40068648A (zh) 软骨再生促进用组合物
JP7332489B2 (ja) ホスホジエステラーゼ３阻害用組成物及び血小板凝集抑制用組成物
JPWO2008136173A1 (ja) スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤
JP4723320B2 (ja) 血中レプチン濃度上昇剤
KR20150110056A (ko) 설포라판을 포함하는 프리온 질병의 예방 또는 치료용 조성물
US20090163579A1 (en) Novel use of nutraceutical compositions
CN115023150B (zh) 硫酸软骨素合成促进用组合物
JP2005089301A (ja) ウシの消化器疾患治療剤
JP6301136B2 (ja) ポリアミンを有効成分とする、軟骨組織の再生を促進するための組成物
CA2577352A1 (en) Canine and equine collagen joint health supplement
HK40079603B (zh) 硫酸软骨素合成促进用组合物
JP2547400B2 (ja) 動物用薬剤
JP4482493B2 (ja) ロタウイルス感染・増殖抑制剤
US20220023253A1 (en) Cannabinoid Compositions and Methods for Treating Joint Pain and Inflammation
KR20250162751A (ko) Dock5 억제제 및 bmp를 포함하는 조골세포 분화 촉진용 조성물 및 이의 용도

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240315

R150 Certificate of patent or registration of utility model

Ref document number: 7457713

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150